Growth inhibition of human melanoma cells by a recombinant arginine deiminase expressed in Escherichia coli

Journal of Veterinary Medical Science

Volumn 71, Issue 10, 2009, Pages 1343-1347

  Kozai, Megumi ^a   Sasamori, Eriko ^a,b   Fujihara, Masatoshi ^a   Yamashita, Tetsuro ^a   Taira, Hideharu ^a   Harasawa, Ryô ^a  

^a IWATE UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

Arginine deiminase; Mycoplasma hominis

Indexed keywords

ANTINEOPLASTIC AGENT; ARGININE DEIMINASE; HYDROLASE; RECOMBINANT PROTEIN;

ARTICLE; CHEMISTRY; ENZYMOLOGY; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MELANOMA; METABOLISM; MOLECULAR CLONING; MYCOPLASMA HOMINIS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CLONING, MOLECULAR; ESCHERICHIA COLI; GENE EXPRESSION REGULATION, BACTERIAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; HYDROLASES; MELANOMA; MYCOPLASMA HOMINIS; RECOMBINANT PROTEINS;

ESCHERICHIA COLI; MYCOPLASMA HOMINIS;

EID: 70350641217     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.001343     Document Type: Article

References (28)

1. Barile, M.F., Schimke, R.T. and Riggs D.B. 1966. Presence of the arginine dihydrolase pathway in Mycoplasma. J. Bacteriol. 91: 189-192.
2. Choi, J.W., Haigh, W.G., Lee, S.P. and Caveat. 1998. Mycoplasma arginine deiminase masquerading as nitric oxide synthase in cell cultures. Biochim. Biophys. Acta. 1404: 314-320.
3. Das, K., Butler, G. H., Kwiatkowski, V., Clark, A.D. Jr., Yadav, P. and Arnold, E. (004. Crystal structures of arginine deiminase with covalent reaction intermediates: implications for catalytic mechanism. Structure (Camb) 12: 657-667.
4. Feun, L., You, M., Wu, C.J., Wangpaichitr, M., Spector, S. and Savaraj, N. 2008. Arginine deprivation as a targeted therapy for cancer. Curr. Pharm. Des. 14: 1049-1057.
5. Galkin, A., Kulakova, L., Sarikaya, E., Lim, K., Howard, A. and Herzberg, O. 2004. Structural insight into arginine degradation by arginine deiminase, an antibacterial and parasite drug target. J. Biol. Chem. 279: 14001-14008.
6. Gong, H., Zolzer, F., von Recklinghausen, G., Havers, W. and Schweigerer, L. 2000. Arginine deiminase inhibits proliferation of human leukemia cells more potently than asparaginase by inducing cell cycle arrest and apoptosis. Leukemia 14: 826-829.
7. Harasawa, R., Koshimizu, K., Kitagawa, M., Asada, K. and Kato, I. 1992. Nucleotide sequence of the arginine deiminase gene of Mycoplasma hominis. Microbiol. Immunol. 36: 661-665.
8. Hong, K. 2006. Characterization of the arginine deiminase of Streptococcus equi subsp. zooepidermicus. Can. J. Microbiol. 52: 868-878.
9. Kim, J.E., Hur, H.J., Lee, K.W. and Lee, H.J. 2007. Anti-inflammatory effects of recombinant arginine deiminase originating from Lactococcus lactis ssp. lactis ATCC 7962. J. Microbiol. Biotechnol. 17: 1491-1497.
10. Kim, R.H., Coates, J.M., Bowles, T.L., McNerney, G.P., Sutcliffe, J., Jung, J.U., Gandour-Edward, R., Chuang, F.Y., Bold, R.J. and Kung, H.J. 2009. Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis. Cancer Res. 15: 700-708.
11. Komada, Y., Zhang, X.L., Zhou, Y.W., Ido, M. and Azuma, E. 1997. Apoptotic cell death of human T lymphoblastoid cells induced by arginine deiminase. Int. J. Hematol. 65: 129-141.
12. Kubo, M., Nishitsuji, H., Kurihara, K., Hayashi, T., Masuda, T. and Kannagi, M. 2006. Suppression of human immunodeficiiency virus type 1 replication by arginine deiminase of Mycoplasma arginini. J. Gen. Virol. 87: 1589-1593.
13. Lu, X., Galkin, A., Herzberg, O. and Dunway-Mariano, D. 2004. Arginine deiminase uses an active-site cysteine in nucleophilic catalysis of L-arginine hydrolysis. J. Am. Chem. Soc. 126: 5374-5375.
14. Misawa, S., Aoshima, M., Takaku, H., Mastumoto, M. and Hayashi, H. 1994. High-level expression of Mycoplasma arginine deiminase in Escherichia coli and its efficient renaturation as an anti-tumor enzyme. J. Biotechno. 361: 145-155.
15. Miyazaki, K., Takaku, H., Umeda, M., Fujita, T., Huang, W., Kimura, T., Yamashita, J. and Horio, T. 1990. Potent growth inhibition of human tumor cells in culture by arginine deiminase purified from a culture medium of a Mycoplasma-infected cell line. Cancer Res. 50: 4522-4527.
16. Murray-Rust, J., Leiper, J., McAlister, M., Phelan, J., Tilley, Santa, S., Maria, J., Vallance, P. and McDonald, N. 2001. Structural insights into the hydrolysis of cellular nitric oxide synthase inhibitors by dimethylarginine dimethylaminohydrolase. Nat. Struct. Biol. 8: 679-683.
17. Ni, Y., Schwaneberg, U. and Sun, Z.H. 2008. Arginine deiminase, a potential anti-tumor drug. Cancer Lett. 261: 1-11.
18. Oginsky, E.L. 1957. Isolation and determination of arginine and citrulline. Methods Enzymol. 3: 639-643.
19. Park, I.S., Kang, S.W., Shin, Y.J., Chae, K.Y., Park, M.O., Kim, M.Y., Wheatley, D.N. and Min, B.H. 2003. Arginine deiminase: a potential inhibitor of angiogenesis and tumour growth. Br. J. Cancer 89: 907-914.
20. Philip, R., Campbell, E. and Wheatley, D.N. 2003. Arginine deprivation, growth inhibition and tumour cell death, Part 2: Enzymatic degradation of arginine in normal and malignant cell cultures. Br. J. Cancer 88: 613-623.
21. Sambook, J. and Russell, W. 2001. In vitro mutagenesis using double-stranded DNA template: selection of mutants with DpnI, pp. 13: 19-13.25. In: title Molecular Cloning, vol. 2. New York Cold Spring Harbor.
22. Schimke, P.T., Berlin, C.M., Sweeney, E.W. and Carroll, W.R. 1966. The generation of energy by the arginine dihydrolase pathway in Mycoplasma hominis 07. J. Biol. Chem. 241: 2228-2236.
23. Shen, L.J., Lin, W.C., Beloussow, K, Hosoya, K, Terasaki, T, Ann, D.K. and Shen, W.C. 2003. Recombinant arginine deiminase as a differential modulator of inducible (iNOS) and endothelial (eNOS) nitric oxide synthetase activity in cultured endothelial cells. Biochem. Pharmacol. 66: 1945-1952.
24. Sugimura, K., Ohno, T., Kusuyama, T. and Azuma, I. 1992. High sensitivity of human melanoma cell lines to the growth inhibitory activity of mycoplasmal arginine deiminase in vitro. Melanoma Res. 2: 191-196.
25. Takaku, H., Matsumoto, M., Misawa, S. and Miyazaki, K. 1995. Anti-tumor activity of arginine deiminase from Mycoplasma arginini and its growth-inhibitory mechanism. Jpn. J Cancer Res. 86: 840-846.
26. Takaku, H., Takase, M., Abe, S., Hayashi, H. and Miyazaki, K. 1992. In vivo anti-tumor activity of arginine deiminase purified from Mycoplasma arginini. Int. J. Cancer 51: 244-249.
27. Thomas, J.B., Holtsberg, F.W., Ensor, C.M., Bomalaski, J.S. and Clark, M.A. 2002. Enzymic degradation of plasma arginine using arginine deiminase inhibits nitric oxide production and protects mice from the lethal effects of tumour necrosis factor and endotoxin. Biochem. J. 363 (Pt 3): 581-587.
28. Wei, Y., Zhou, H., Sun, Y., He, Y. and Luo, Y. 2007. Insight into the catalytic mechanism of arginine deiminase: functional studies on the crucial sites. Proteins 66: 740-750.